{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:42:21Z","timestamp":1771065741949,"version":"3.50.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T00:00:00Z","timestamp":1290038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Serum uric acid (UA) is a strong endogenous antioxidant. Since oxidative stress has been linked to osteoporosis, we examined the association between serum UA levels and bone mineral density (BMD), prevalent vertebral and nonvertebral fractures, and laboratory measures such as calcitropic hormones and bone turnover marker levels. This cross-sectional analysis consisted of 1705 community-dwelling men aged 70 years or over who participated in the baseline part of the Concord Health and Ageing in Men Project (CHAMP), a population-based study of older men in Sydney, Australia. BMD at all sites was significantly higher among men with serum UA levels above the group median than among men with UA levels below the median. In multiple regression analyses adjusted for potential confounders, serum UA remained associated with BMD at all sites (\u03b2\u2009=\u20090.12 to 0.14, p\u2009&amp;lt;\u2009.001), serum calcium (\u03b2\u2009=\u20090.11, p\u2009=\u2009.001), parathyroid hormone (\u03b2\u2009=\u20090.09, p\u2009=\u2009.002), 25-hydroxyvitamin D (\u03b2\u2009=\u20090.09, p\u2009=\u2009.005), and was negatively associated with urinary excretion amino-terminal cross-linked telopeptide of type 1 collagen (\u03b2\u2009=\u2009\u20130.09, p\u2009=\u2009.006). Overall, serum UA accounted for 1.0% to 1.44% of the variances in BMD (R2\u2009=\u20090.10 to 0.22). In multiple logistic regression analyses, above-median serum UA levels were associated with a lower prevalence of osteoporosis at the femoral neck [odds ratio (OR)\u2009=\u20090.42, 95% confidence interval (CI) 0.22\u20130.81, p\u2009=\u2009.010) and lumbar spine (OR\u2009=\u20090.44, 95% CI 0.23\u20130.86, p\u2009=\u2009.016) and a lower prevalence of vertebral (OR\u2009=\u20090.62, 95% CI 0.43\u20130.91, p\u2009=\u2009.015) and nonvertebral (OR\u2009=\u20090.51, 95% CI 0.29\u20130.89, p\u2009=\u2009.018) fractures. In conclusion, higher serum UA levels are associated with higher BMD at all skeletal sites and with a lower prevalence of vertebral and nonvertebral fractures in older men. \u00a9 2011 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.286","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T18:17:54Z","timestamp":1290104274000},"page":"955-964","source":"Crossref","is-referenced-by-count":122,"title":["Serum uric acid is associated with bone health in older men: A cross-sectional population-based study"],"prefix":"10.1093","volume":"26","author":[{"given":"Iraj","family":"Nabipour","sequence":"first","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N","family":"Sambrook","sequence":"additional","affiliation":[{"name":"Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona M","family":"Blyth","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, Australia"},{"name":"Centre for Education and Research on Ageing, University of Sydney, Concord Campus, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret R","family":"Janu","sequence":"additional","affiliation":[{"name":"Sydney South West Pathology Service, Concord Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise M","family":"Waite","sequence":"additional","affiliation":[{"name":"Centre for Education and Research on Ageing, University of Sydney, Concord Campus, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasi","family":"Naganathan","sequence":"additional","affiliation":[{"name":"Centre for Education and Research on Ageing, University of Sydney, Concord Campus, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Handelsman","sequence":"additional","affiliation":[{"name":"Department of Andrology, ANZAC Research Institute, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G","family":"Le Couteur","sequence":"additional","affiliation":[{"name":"Centre for Education and Research on Ageing, University of Sydney, Concord Campus, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G","family":"Cumming","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, Australia"},{"name":"Centre for Education and Research on Ageing, University of Sydney, Concord Campus, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J","family":"Seibel","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Concord Hospital, University of Sydney, Sydney, Australia"},{"name":"Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,11,18]]},"reference":[{"key":"2024020318083011200_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","article-title":"The role of hyperuricemia and gout in kidney and cardiovascular disease","volume":"75","author":"Edwards","year":"2008","journal-title":"Cleve Clin J Med."},{"key":"2024020318083011200_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3949\/ccjm.75.Suppl_5.S5","article-title":"Clinical manifestations of hyperuricemia and gout","volume":"75","author":"Mandell","year":"2008","journal-title":"Cleve Clin J Med."},{"key":"2024020318083011200_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/BOR.0b013e3283257b96","article-title":"The role of hyperuricemia in vascular disorders","volume":"21","author":"Edwards","year":"2009","journal-title":"Curr Opin Rheumatol."},{"key":"2024020318083011200_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","article-title":"The paradoxical relationship between serum uric acid and cardiovascular disease","volume":"392","author":"Lippi","year":"2008","journal-title":"Clin Chim Acta."},{"key":"2024020318083011200_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","article-title":"Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 mean and women in the Apolipoprotein MOrtality RISk study (AMORIS)","volume":"266","author":"Holme","year":"2009","journal-title":"J Intern Med."},{"key":"2024020318083011200_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfp042","article-title":"Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure","volume":"11","author":"Bergamini","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"2024020318083011200_bib7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension."},{"key":"2024020318083011200_bib8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertens."},{"key":"2024020318083011200_bib9","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0b013e32830e4945","article-title":"Uric acid: bystander or culprit in hypertension and progressive renal disease","volume":"26","author":"Men","year":"2008","journal-title":"J Hypertens."},{"key":"2024020318083011200_bib10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2024020318083011200_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes","volume":"31","author":"Dehghan","year":"2008","journal-title":"Diabetes Care."},{"key":"2024020318083011200_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/dc09-0275","article-title":"Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study","volume":"32","author":"Kramer","year":"2009","journal-title":"Diabetes Care."},{"key":"2024020318083011200_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","article-title":"Hyperuricemia, gout and the metabolic syndrome","volume":"20","author":"Puig","year":"2008","journal-title":"Curr Opin Rheumatol."},{"key":"2024020318083011200_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11739-008-0141-3","article-title":"The conundrum of hyperuricemia, metabolic syndrome, and renal disease","volume":"3","author":"Nakagawa","year":"2008","journal-title":"Intern Emerg Med."},{"key":"2024020318083011200_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2169\/internalmedicine.48.2426","article-title":"Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men","volume":"48","author":"Oda","year":"2009","journal-title":"Intern Med."},{"key":"2024020318083011200_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","article-title":"Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity","volume":"40","author":"Watanabe","year":"2002","journal-title":"Hypertension."},{"key":"2024020318083011200_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00360-008-0291-7","article-title":"Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society","volume":"179","author":"Johnson","year":"2009","journal-title":"J Comp Physiol B."},{"key":"2024020318083011200_bib18","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024020318083011200_bib19","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr Pharm Des."},{"key":"2024020318083011200_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00415-009-5170-y","article-title":"Serum uric acid and risk of multiple sclerosis","volume":"256","author":"Massa","year":"2009","journal-title":"J Neurol."},{"key":"2024020318083011200_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clineuro.2009.06.012","article-title":"Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration","volume":"111","author":"Andreadou","year":"2009","journal-title":"Clin Neurol Neurosurg."},{"key":"2024020318083011200_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2009.06.002","article-title":"Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress","volume":"285","author":"Keizman","year":"2009","journal-title":"J Neurol Sci."},{"issue":"(Pt 2)","key":"2024020318083011200_bib23","first-page":"377","article-title":"Serum uric acid and cognitive function and dementia","volume":"132","author":"Euser","year":"2009","journal-title":"Brain."},{"key":"2024020318083011200_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1210\/jc.2002-021496","article-title":"Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study","volume":"88","author":"Maggio","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318083011200_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00198-007-0457-2","article-title":"Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids","volume":"19","author":"Sugiura","year":"2008","journal-title":"Osteoporos Int."},{"key":"2024020318083011200_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jbspin.2009.02.005","article-title":"Antioxidant status in patients with osteoporosis: a controlled study","volume":"76","author":"Sendur","year":"2009","journal-title":"Joint Bone Spine."},{"key":"2024020318083011200_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3945\/ajcn.2008.26388","article-title":"Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study","volume":"89","author":"Sahni","year":"2009","journal-title":"Am J Clin Nutr."},{"key":"2024020318083011200_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2474-8-124","article-title":"Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes","volume":"8","author":"S\u00e1nchez-Rodr\u00edguez","year":"2007","journal-title":"BMC Musculoskelet Disord."},{"key":"2024020318083011200_bib29","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/jn\/138.10.1931","article-title":"High vitamin C intake is associated with lower 4-year bone loss in elderly men","volume":"138","author":"Sahni","year":"2008","journal-title":"J Nutr."},{"key":"2024020318083011200_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.freeradbiomed.2009.05.031","article-title":"Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol","volume":"47","author":"Ostman","year":"2009","journal-title":"Free Radic Biol Med."},{"key":"2024020318083011200_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ije\/dyn071","article-title":"Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP)","volume":"38","author":"Cumming","year":"2009","journal-title":"Int J Epidemiol."},{"key":"2024020318083011200_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","article-title":"The Physical Activity Scale for the Elderly (PASE): development and evaluation","volume":"46","author":"Washburn","year":"1993","journal-title":"J Clin Epidemiol."},{"key":"2024020318083011200_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0009-9120(99)00051-X","article-title":"Moderate alcohol consumption: the gentle face of Janus","volume":"32","author":"Goldberg","year":"1999","journal-title":"Clin Biochem."},{"key":"2024020318083011200_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3945\/ajcn.2008.26765","article-title":"Effects of beer, wine, and liquor intakes on bone mineral density in older men and women","volume":"89","author":"Tucker","year":"2009","journal-title":"Am J Clin Nutr."},{"key":"2024020318083011200_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1440783309103342","article-title":"The AUSEI06 A new socioeconomic index for Australia","volume":"45","author":"McMillan","year":"2009","journal-title":"J Sociol."},{"key":"2024020318083011200_bib36","first-page":"1269","author":"Australian Bureau of Statistics"},{"key":"2024020318083011200_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2008.03.020","article-title":"The amino- and carboxyterminal cross-linked telopeptides of collagen type I: a comparative review","volume":"393","author":"Herrmann","year":"2008","journal-title":"Clin Chim Acta."},{"key":"2024020318083011200_bib38","doi-asserted-by":"crossref","first-page":"27298","DOI":"10.1074\/jbc.M702811200","article-title":"Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription","volume":"282","author":"Almeida","year":"2007","journal-title":"J Biol Chem."},{"key":"2024020318083011200_bib39","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/art.23488","article-title":"Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells","volume":"58","author":"Dalbeth","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2024020318083011200_bib40","first-page":"1738","article-title":"[Parathyroid function and uric acid metabolism]","volume":"59","author":"Yoneda","year":"1983","journal-title":"Nippon Naibunpi Gakkai Zasshi."},{"key":"2024020318083011200_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2796.1998.00366.x","article-title":"Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment","volume":"244","author":"Valdemarsson","year":"1998","journal-title":"J Intern Med."},{"key":"2024020318083011200_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/rheumatology\/ken416","article-title":"The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial","volume":"48","author":"Dalbeth","year":"2009","journal-title":"Rheumatology (Oxf)."},{"key":"2024020318083011200_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.1987.tb04863.x","article-title":"Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide","volume":"59","author":"Kohri Takada","year":"1987","journal-title":"Br J Urol."},{"key":"2024020318083011200_bib44","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med."},{"key":"2024020318083011200_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","article-title":"Safety of parathyroid hormone for the treatment of osteoporosis","volume":"6","author":"Miller","year":"2008","journal-title":"Curr Osteoporos Rep."},{"key":"2024020318083011200_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int."},{"key":"2024020318083011200_bib47","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1210\/jc.2004-0249","article-title":"Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance","volume":"89","author":"Laspa","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318083011200_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MAJ.0b013e31815b218f","article-title":"Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid","volume":"336","author":"Unluturk","year":"2008","journal-title":"Am J Med Sci."},{"key":"2024020318083011200_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.rdc.2006.02.006","article-title":"Renal urate transport","volume":"32","author":"Mount","year":"2006","journal-title":"Rheum Dis Clin North Am."},{"key":"2024020318083011200_bib50","first-page":"319","article-title":"The aging liver","volume":"12","author":"Le Couteur","year":"2009","journal-title":"Geriatr Aging."},{"key":"2024020318083011200_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4615-5381-6_11","article-title":"Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout","volume":"431","author":"Takahashi","year":"1998","journal-title":"Adv Exp Med Biol."},{"key":"2024020318083011200_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000282801","article-title":"Relationship between 1,25-dihydroxyvitamin-D, calcium and uric acid in urinary stone formers","volume":"56","author":"Jarrar","year":"1996","journal-title":"Urol Int."},{"key":"2024020318083011200_bib53","first-page":"3930","article-title":"Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability","volume":"83","author":"Orwoll","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318083011200_bib54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(05)66911-5","article-title":"Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men","volume":"366","author":"Holden","year":"2005","journal-title":"Lancet."},{"key":"2024020318083011200_bib55","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00198-005-1866-8","article-title":"Factors associated with the lumbar spine and proximal femur bone mineral density in older men","volume":"16","author":"Cauley","year":"2005","journal-title":"Osteoporos Int."},{"key":"2024020318083011200_bib56","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"key":"2024020318083011200_bib57","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med."},{"issue":"(Suppl 113)","key":"2024020318083011200_bib58","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int."},{"key":"2024020318083011200_bib59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00198-003-1435-y","article-title":"Relationship between age, renal function and bone mineral density in the US population","volume":"14","author":"Klawansky","year":"2003","journal-title":"Osteoporos Int."},{"key":"2024020318083011200_bib60","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int."},{"key":"2024020318083011200_bib61","first-page":"1027","article-title":"Obesity as a protective factor for postmenopausal osteoporosis","volume":"20","author":"Albala","year":"1996","journal-title":"Int J Obes Relat Metab Disord."},{"key":"2024020318083011200_bib62","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1359\/jbmr.070608","article-title":"Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study","volume":"22","author":"Ferrar","year":"2007","journal-title":"J Bone Miner Res."},{"key":"2024020318083011200_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.286","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/5\/955\/56558323\/286_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/5\/955\/56558323\/286_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:56:24Z","timestamp":1710341784000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/26\/5\/955-964\/7598010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,18]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,11,18]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.286","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,5,1]]},"published":{"date-parts":[[2010,11,18]]}}}